Remove 2027 Remove Competition Remove Healthcare Provider Remove Prospecting
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Results from this trial are scheduled to be released in October 2027, and may allow non-diabetic obese patients to have access to Mounjaro.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Results from this trial are scheduled to be released in October 2027, and may allow non-diabetic obese patients to have access to Mounjaro.

Medical 98